http://www.unboundmedicine.com/medline/ebm/research/daptomycinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19919306/full_citation/Enhanced_Expression_of_dltABCD_Is_Associated_with_the_Development_of_Daptomycin_Nonsusceptibility_in_a_Clinical_Endocarditis_Isolate_of_Staphylococcus_aureus_Yang SJ, Kreiswirth BN, Sakoulas G, et al. 
Enhanced Expression of dltABCD Is Associated with the Development of Daptomycin Nonsusceptibility in a Clinical Endocarditis Isolate of Staphylococcus aureus. [JOURNAL ARTICLE]
J Infect Dis 2009 Dec 15; 200(12):1916-1920.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19917756/full_citation/Efficacy_profile_of_daptomycin_for_the_treatment_of_invasive_as_compared_to_non_invasive_pulmonary_infections_with_S__pneumoniae_Henken S, Bohling J, Martens-Lobenhoffer J, et al. 
Efficacy profile of daptomycin for the treatment of invasive as compared to non-invasive pulmonary infections with S. pneumoniae. [JOURNAL ARTICLE]
Antimicrob Agents Chemother 2009 Nov 16.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19917746/full_citation/Ceftobiprole_is_Superior_to_Vancomycin_Daptomycin_and_Linezolid_for_the_Treatment_of_Methicillin_Resistant_Staphylococcus_aureus_Experimental_Endocarditis_in_Rabbits_Tattevin P, Basuino L, Bauer D, et al. 
Ceftobiprole is Superior to Vancomycin, Daptomycin, and Linezolid, for the Treatment of Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis in Rabbits. [JOURNAL ARTICLE]
Antimicrob Agents Chemother 2009 Nov 16.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19915718/full_citation/The_Bacterial_Defensin_Resistance_Protein_MprF_Consists_of_Separable_Domains_for_Lipid_Lysinylation_and_Antimicrobial_Peptide_Repulsion_Ernst CM, Staubitz P, Mishra NN, et al. 
The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion. [Journal Article]
PLoS Pathog 2009 Nov; 5(11):e1000660.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19911938/full_citation/Telavancin:_A_Novel_Lipoglycopeptide_Saravolatz LD, Stein GE, Johnson LB 
Telavancin: A Novel Lipoglycopeptide. [JOURNAL ARTICLE]
Clin Infect Dis 2009 Nov 13.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19910570/full_citation/Intraperitoneal_daptomycin_used_to_successfully_treat_vancomycin_resistant_enterococcus_peritonitis_Hassoun AA, Coomer RW, Mendez-Vigo L 
Intraperitoneal daptomycin used to successfully treat vancomycin-resistant enterococcus peritonitis. [Journal Article]
Perit Dial Int 2009 Nov-Dec; 29(6):671-3.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19909893/full_citation/Antibiotics_for_gram_positive_bacterial_infections:_vancomycin_teicoplanin_quinupristin/dalfopristin_oxazolidinones_daptomycin_dalbavancin_and_telavancin_Nailor MD, Sobel JD 
Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin. [Journal Article]
Infect Dis Clin North Am 2009 Dec; 23(4):965-82, ix.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19898996/full_citation/Development_and_validation_of_a_simultaneous_extraction_procedure_for_HPLC_MS_quantification_of_daptomycin_amikacin_gentamicin_and_rifampicin_in_human_plasma_Baietto L, D'Avolio A, De Rosa FG, et al. 
Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma. [JOURNAL ARTICLE]
Anal Bioanal Chem 2009 Nov 9.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19896341/full_citation/High_dose_daptomycin_for_the_treatment_of_endocarditis_caused_by_Staphylococcus_aureus_with_intermediate_susceptibility_to_glycopeptides_Lichterfeld M, Ferraro MJ, Davis BT 
High-dose daptomycin for the treatment of endocarditis caused by Staphylococcus aureus with intermediate susceptibility to glycopeptides. [LETTER]
Int J Antimicrob Agents 2009 Nov 4.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19891570/full_citation/Early_experience_with_high_dosage_daptomycin_for_prosthetic_infections_De Rosa FG, Mollaretti O, Cometto C, et al. 
Early experience with high-dosage daptomycin for prosthetic infections. [Comment, Letter]
Clin Infect Dis 2009 Dec 1; 49(11):1772-3.
Full Citation | Find Related Articles